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Background. The outcome of patients undergoing a single-lung transplant in the setting of an aborted bilateral lung transplant
is unclear. Methods. A retrospective review of single lung transplants at an institutional program. Results. Of the 543 lung
transplants performed over the last 10 years, 31 (5.7%) were single-lung transplants. Nineteen of 31 (61%) were planned singlelung transplants, while 12/31 (39%) were intraoperatively aborted, double lung transplants converted to single-lung transplants.
The aborted and planned groups were similar in age, lung allocation score and NYHA status. The reasons for aborted double
lung transplantation were cardiac/hemodynamic instability 4/12 (33%), diﬃcult pneumonectomy 3/12 (25%), size mismatch
4/12(33%), and technical issues 1/12 (8%). The aborted group had higher CPB utilization (5/12 versus 1/19, P = .02), similar
ischemic times (260 versus 234 min) and similar incidence of grade 3 primary graft dysfunction (6/12 versus 3/19, P = .13). ECMO
was required for graft dysfunction in 2 patients in the aborted group. The one and two-year survival was 84% and 79% in the
planned group and 62% and 52% in the aborted group, respectively. Conclusions. Patients undergoing single-lung transplantation
in the setting of an aborted bilateral lung transplant may be at a higher risk of worse outcomes.

1. Background
More than two thousand five hundred lung transplants were
performed worldwide in 2007, and the number has been
gradually increasing over the last decade [1]. Two common
diagnoses for lung transplant recipients, emphysema and
pulmonary fibrosis, may be treated by either single, or
bilateral lung transplantation. Proponents of either approach
have good arguments in their favor. In general, patients
undergoing single-lung transplantation (SLT) have similar
short-term and slightly lower long-term survival compared
to bilateral lung transplantation (BLT) [1, 2].
Usually, the decision to implant one lung or to perform a
bilateral transplant is made prior to the operation. Individual
center preference, patient factors, and whether one or two
donor lungs are being oﬀered are important variables in
the decision making process. Our anecdotal experience has
shown that some patients ultimately undergo SLT in the
setting of an aborted BLT. Registry data and published

literature do not separately report this population and their
outcomes are clubbed with the SLT cohort. This led us
to investigate our institutional database for outcomes in
patients undergoing SLT in the setting of aborted BLT.

2. Patients and Methods
We performed a retrospective review of a prospectively
maintained institutional adult lung transplantation database
from January 2000 through December 2009. All patients
who had undergone SLT were reviewed. Demographic
data, perioperative data and outcomes were abstracted. All
operative reports were reviewed to establish if the operation
was a planned SLT or an aborted BLT. Specific causes for the
intraoperative decision were recorded. Operative mortality
included those patients who died within the first 30 days after
the operation or later during the same hospitalization.
Comparisons between the two groups were made with
unpaired, two-tailed t tests for means of normally distributed
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continuous variables and Wilcoxon rank sum tests for
skewed data. Either X 2 or Fisher exact tests were used to
compare categorical data. Kaplan-Meier analysis was used to
estimate survival. Followup was censored for end of study
and expiration. All data analyses were done using SPSS
(SPSS 13.0 for Windows; SPSS Inc, Chicago, Ill). P value
less than .05 was considered statistically significant, and
adjustments were not made for multiple comparisons.
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3. Results
Of the 543 lung transplants performed from 01/2000 to
12/2009, thirty-one (5.7%) were single-lung transplants.
Nineteen of 31 (61%) were planned single-lung transplants
while 12/31 (39%) were intraoperatively aborted, double
lung transplants converted to single-lung transplants. The
aborted and planned groups were similar in age, gender,
mean lung allocation score, waiting list time, preoperative
NYHA status, and mean pulmonary artery pressure (data
not shown). All donors were evaluated with the standard
criteria [3], and extended criteria donors were not utilized.
The donors for the two groups were comparable in age and
PaO2 (data not shown). Forty two percent of donors in the
aborted group were distant compared to 11% in the planned
group (P = .078), and this did not result in a diﬀerence in
cold ischemia times. (Table 1)
The diagnoses in the aborted group were emphysema
5/12 (42%), Pulmonary fibrosis 5/12 (42%), others 2/12
(16%) (Bronchiolitis obliterans syndrome 1, Lymphangioleiomyomatosis 1) and were similar to the planned group.
The reasons for aborted double lung transplantation
were cardiac/hemodynamic instability 4/12 (33%), diﬃcult
pneumonectomy 3/12 (25%), size mismatch 4/12 (33%),
and technical issues with atrial anastomosis 1/12 (8%). In
comparison with the planned group, the aborted group had
higher CPB utilization and higher incidence of secondary
chest closure (Table 1). Two patients in the aborted group
required ECMO support for severe PGD (primary graft
dysfunction). The only perioperative death occurred in the
aborted group. The groups were similar in early postoperative outcomes of PGD, length of mechanical ventilation and
airway complications (Table 2). The median hospital stay was
23 days for the aborted group versus 13 days for the planned
group (P = .067). The one- and two-year survival was 84%
and 79% in the planned group and 62% and 52% in the
aborted group, respectively (Table 2, Figure 1).
In all our cases in the aborted group, the issues precipitating the decision were technical (pleural adhesions, bleeding)
or physiologic (hemodynamic instability, poor oxygenation).
In many instances, more than one factor was considered.
In general, two patterns were recognized. The first group of
patients (n = 7) had fused pleural spaces or an overwhelming
mismatch in function between the two native lungs, and an
oversized donor lung that had good function immediately
after implantation in place of the native lung with poorer
function. The decision to implant only one lung was made
early in most of these patients, and they generally had a
smooth postoperative course. The second group of patients
(n = 5) presented with significant bleeding or hemodynamic
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Figure 1: Kaplan Meier Survival stratified by Groups.

problems during the first pneumonectomy or implantation,
usually requiring urgent cardiopulmonary bypass. These
patients generally had a diﬃcult early postoperative course
often with significant transfusion requirements, reoperation
for bleeding, early respiratory failure, and the need for
ECMO in two cases. Although no specific preoperative risk
factors predicted the need to abort a BLT and perform a SLT
in our patients, a review of the operative records indicated
that an early decision to implant only one lung led to
smoother postoperative course

4. Discussion
The decision to perform BLT or SLT is often dependent upon
institutional preference. The proponents of SLT argue that
it is an easier procedure to perform, has less morbidity and
mortality associated with it, and results in shorter ischemic
time. There is also the societal benefit of two recipients
benefiting from one donor. Proponents of BLT have argued
that BLTs result in fewer ventilation/perfusion mismatches,
are easier to care for in the perioperative period, will
provide better overall lung function, are protective against
the physiologic manifestations of obliterative bronchiolitis,
and oﬀer a better long-term survival [1, 2, 4–6]. Additionally,
the longer ischemic times associated with BLT have not led to
clinical sequelae [7, 8]. In patients with pulmonary fibrosis,
SLT seems to have short-term survival benefit but long-term
harm; whereas BLT seems to have short-term harm but longterm survival benefit [9]. BLT leads to longer survival than
SLT in patients with COPD, especially those who are younger
than 60 years [10].
Recent registry data have shown that the utilization of
BLT is on the rise [1, 2]. Unadjusted registry data also show
that BLT may provide intermediate term survival advantage
over SLT double lung conditional 1/2-life = 9.0 years versus
single-lung conditional 1/2-life = 6.4 Years where conditional
half life is the time to 50% survival for the subset of recipients
who were alive at 1 year after transplantation. We preferentially perform BLT whenever feasible. However, owing to
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Table 1: Operative data.

Variable
Ischemic time (mean, min)
Side of allograft
Right
Left
Cardiopulmonary bypass
ECMO requirement
Chest left open after transplant
Early reoperation (bleeding/tracheostomy)

Aborted bilateral (n = 12)
260.1 ± 52.4

Planned single (n = 19)
234.4 ± 27.5

6 (50.0%)
6 (50.0%)
5 (41.7%)
2 (16.7%)
3 (25%)
6 (50%)

7 (36.8%)
12 (63.2%)
1 (5.3%)
0
0
4 (21.1%)

P value
.129
.710
.022
.142
.049
.127

Table 2: Followup and outcomes data.
Variable
Primary graft dysfunction (grade 3)
Length of mechanical ventilation (days)
Length of stay in ICU (days)
Length of stay in hospital (days)
Mean followup time (years)
Intervention for Airway Complication
KM Survival
1 year
2 year
3 years

Aborted bilateral (n = 12)
6 (50.0%)
2 (IQR: 1–41)
4 (IQR: 2–30)
23 (IQR: 9–52)
2.0 ± 3.0
1 (8.3%)

Planned single (n = 19)
4 (21.1%)
2 (IQR: 1-2)
3 (IQR: 2-3)
13 (IQR: 10–19)
3.6 ± 2.4
3 (15.8%)

P value
.127
.120
.093
.067
.38
1.000

61.9% (n = 6)
51.6% (n = 5)
51.6% (n = 4)

84.2% (n = 16)
79% (n = 13)
72.4% (n = 10)

.941

IQR: Interquartile range, KM: Kaplan Meier.

the limited number of organs available, we recognize that
SLT is a reasonable option for older patients with COPD
and IPF [11]. It is unlikely that the debate between SLT and
BLT proponents will be conclusively settled in the near future
[12, 13]. In this setting, ongoing analyses of outcomes for
both groups and subgroups would be useful.
Thirty-nine percent of the SLTs we performed over the
study period were in the setting of aborted BLTs. This number is likely to be lower at institutions where SLT is performed
more frequently or preferentially for emphysema and pulmonary fibrosis. Published literature and registry data do not
have any information on the true incidence of this scenario.
We were able to show a higher need for cardiopulmonary
bypass, delayed chest closure, and a trend towards longer
ICU and hospital stay in the aborted group. Also, despite the
survival curves appearing divergent, statistical diﬀerence was
not achieved between the two groups. This is likely related to
the small number of patients available for analysis.
Outcomes in lung transplantation are predicated upon
technical success. We are now prospectively recording episodes of intraoperative conversion from BLT to SLT in our
institutional database. Collection of similar data at registry
level will provide an insight into the incidence of this event
and clinical scenarios where it occurs most frequently. This
will be useful in not only better planning for a smoother
operation at institutional level but may lead to a societal
benefit with two planned single-lung transplants occurring
instead of one single-lung transplant in an aborted planned
bilateral procedure.

5. Conclusions
Patients undergoing single-lung transplantation in the setting of an aborted bilateral lung transplant may be at a higher
risk of worse outcomes. In outcomes analyses, this subset of
single-lung transplants should be identified.
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